Therefore, this study aimed to explore the role of the SUVmax of 18F-FDG PET/CT in CRC by analyzing the association of the SUVmax with the clinical features of CRC, KRAS mutation, and the Ki-67 index. This evidence concerns the gene KRAS and colorectal carcinoma.